The U.S. Food and Drug Administration approved emergency use for a new, at-home coronavirus testing kit.

On Tuesday, the agency authorized an all-in-one COVID-19 diagnostic test from Lucira Health, Inc, allowing users to receive results in 30 minutes or less. The single-use test swirls a self-collected sample swab inside a vial and then displays a result.

Recommended Stories

Pfizer says COVID-19 pill 89% effective against severe illness

Vaccine experts question fourth shot as companies seek expanded authorization

Moderna COVID-19 vaccine receives full FDA approval for adults